ARCHIVES

Targeting Men At High Risk Finds More Head & Neck Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

Foreeman, Brinker, Jako Appointed To Cancer Panel

April 19, 1991